KRC official logo KRC
KRC 3-star rating from Upturn Advisory
Kilroy Realty Corp (KRC) company logo

Kilroy Realty Corp (KRC)

Kilroy Realty Corp (KRC) 3-star rating from Upturn Advisory
$40.46
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/12/2025: KRC (3-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 3 star rating for performance

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Number of Analysts

3 star rating from financial analysts

17 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $42.93

1 Year Target Price $42.93

Analysts Price Target For last 52 week
$42.93 Target price
52w Low $26.31
Current$40.46
52w High $44.46

Analysis of Past Performance

Type Stock
Historic Profit 46.22%
Avg. Invested days 40
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 3.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/12/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 4.83B USD
Price to earnings Ratio 14.93
1Y Target Price 42.93
Price to earnings Ratio 14.93
1Y Target Price 42.93
Volume (30-day avg) 17
Beta 1.08
52 Weeks Range 26.31 - 44.46
Updated Date 12/12/2025
52 Weeks Range 26.31 - 44.46
Updated Date 12/12/2025
Dividends yield (FY) 5.32%
Basic EPS (TTM) 2.71

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 28.68%
Operating Margin (TTM) 28.86%

Management Effectiveness

Return on Assets (TTM) 1.87%
Return on Equity (TTM) 6.21%

Valuation

Trailing PE 14.93
Forward PE 70.92
Enterprise Value 9098004702
Price to Sales(TTM) 4.29
Enterprise Value 9098004702
Price to Sales(TTM) 4.29
Enterprise Value to Revenue 8.07
Enterprise Value to EBITDA 10.96
Shares Outstanding 118305702
Shares Floating 99128348
Shares Outstanding 118305702
Shares Floating 99128348
Percent Insiders 0.99
Percent Institutions 132.31

About Kilroy Realty Corp

Exchange NYSE
Headquaters Los Angeles, CA, United States
IPO Launch date 1997-01-28
CEO & Director Ms. Angela M. Aman
Sector Real Estate
Industry REIT - Office
Full time employees 229
Full time employees 229

Kilroy is a leading U.S. landlord and developer, with operations in San Diego, Los Angeles, the San Francisco Bay Area, Seattle, and Austin. The Company has earned global recognition for sustainability, building operations, innovation, and design. As a pioneer and innovator in the creation of a more sustainable real estate industry, the Company's approach to modern business environments helps drive creativity and productivity for some of the world's leading technology, entertainment, life science, and business services companies. The Company is a publicly traded real estate investment trust ("REIT") and member of the S&P MidCap 400 Index with more than seven decades of experience developing, acquiring, and managing office, life science, and mixed-use projects. As of June 30, 2025, Kilroy's stabilized portfolio totaled approximately 16.4 million square feet of primarily office and life science space that was 80.8% occupied and 83.5% leased. The Company also had approximately 1,000 residential units in Hollywood and San Diego, which had a quarterly average occupancy of 93.8%. In addition, the Company had one development project in the tenant improvement phase totaling approximately 875,000 square feet with a total estimated investment of $1.0 billion and two life science redevelopment projects in the tenant improvement phase totaling approximately 100,000 square feet with total estimated redevelopment costs of $85.0 million.